Increase therapeutic antibody efficacy and potency with a CHOSOURCE cell line that eliminates the cell's natural fucosylation activity.
With over 100+ licenses and filings access our ADCC+ cell line and improve your therapeutic antibody treatments.
CHOSOURCE™ TnT transposon technology
Simplifying cell line development and enabling acceleration of biologic development programs
With our TnT transposon technology that consists of the TnT transposon vector and TnT transposase, you can redefine your biotherapeutic development and manufacturing workflows.
From reliable workhorse to state-of-the-art protein powerhouse
マンチェスター大学バイオテクノロジー学部のAlan Dickson教授とCell Culture Dishが制作したポッドキャストです。
Video: The CHOSOURCE™ expression platform for advanced bioproduction
Learn how the CHO-K1 GS knockout expression platform enables rapid identification of clones expressing high levels of recombinant therapeutic protein during development of a stable cell line.